Comparing the current results to its competitors, Vivani Medical Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 12.93 %, recorded in the same quarter.
Vivani Medical Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 810.86 %
July 11, 2024
Vivani Medical Sets Sights on Breakthrough Miniature Obesity Implant ProgramALAMEDA, Calif. - Vivani Medical, Inc. (Nasdaq: VANI), a pioneering biopharmaceutical company specializing in long-term drug implants, recently provided an update on its clinical development plans for the NPM-115 program. This innovative initiative aims to tackle the pressing issue of chronic weight management through the development of a groundbreaking miniature, long-term GLP-1 obesity implant.Vivani Medical has announced that it expects to commence the first clinical study for the NPM-115 program in the fourth quarter of 2024, pending regulatory clearance in Australia. The study will evaluate the efficacy and safety of the investi...
DarioHealth Corp's business model revolves around providing digital health solutions to individuals with chronic diseases. Through their mobile health platform, they offer personalized tools and remote monitoring capabilities that empower patients to proactively manage their conditions. By combining software, data analytics, and medical devices, DarioHealth aims to enhance patient engagement, improve health outcomes, and reduce healthcare costs.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Modular Medical Inc operates with a business model focused on designing and manufacturing modular medical units, offering cost-effective and customizable solutions for healthcare providers looking to expand their facilities rapidly and efficiently. They aim to deliver innovative and turnkey solutions that can be easily deployed and scaled to meet the specific needs of their clients.
Insulet Corporation operates under a business model where they design, develop, and market innovative tubeless insulin delivery systems for people with diabetes. Their main product, the Omnipod System, is a wearable device that provides continuous insulin delivery without the need for traditional insulin pumps and tubing. This unique business model focuses on improving the quality of life for individuals with diabetes by offering a convenient and user-friendly insulin management solution.
Sources:
Vivani Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Vivani Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
